BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque
BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque

Immobilized BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque, hFc Tag at 1 μg/ml (100 μL/well) on the plate. Dose response curve for Biotinylated Anti-BCMA Antibody, hFc Tag with the EC50 of 9.1 ng/ml determined by ELISA.

BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque

The purity of BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC.

BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque

BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque

B-cell maturation antigen (BCMA or BCM), also known as tumor necrosis factor receptor superfamily member 17 (TNFRSF17), is a protein that in humans is encoded by the TNFRSF17 gene.TNFRSF17 is a cell surface receptor of the TNF receptor superfamily which recognizes B-cell activating factor (BAFF).
Z03853
¥74,617.00

Ask us a question
Product Introduction
Species Cynomolgus/Rhesus macaque
Protein Construction
BCMA/TNFRSF17 (Met1-Ala53)
Accession # A0A2K5UD97 / F7FFA0		 hFc
N-term C-term
Purity > 95% as determined by Bis-Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 31.5 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 35-45 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4.
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque
    • BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque

    Immobilized BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque, hFc Tag at 1 μg/ml (100 μL/well) on the plate. Dose response curve for Biotinylated Anti-BCMA Antibody, hFc Tag with the EC50 of 9.1 ng/ml determined by ELISA.

  • BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque
    • BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque

    The purity of BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC.

  • BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque
    • BCMA/TNFRSF17 HFc Chimera, Cynomolgus/Rhesus Macaque

    BCMA/TNFRSF17 hFc Chimera, Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background BCMA (B-cell maturation antigen), also called TNFRSF17, is encoded by the TNFRSF17 gene. It acts as a cell surface receptor of the TNF receptor superfamily. BCMA recognizes B-cell activating factor (BAFF). It interacts with the B-cell activating factor TNFSF13B.
Synonyms CD269; TNFRSF17; BCMA; BCM; TNFRSF13A

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.